LORD, ABBETT & CO. LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 192 filers reported holding HAEMONETICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2019$6,724,000
-66.9%
76,862
-62.2%
0.02%
-70.3%
Q4 2018$20,326,000
+292.2%
203,158
+56.4%
0.07%
+516.7%
Q3 2013$5,182,000
-86.4%
129,928
-85.9%
0.01%
-86.4%
Q2 2013$38,030,000919,7000.09%
Other shareholders
HAEMONETICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders